106 related articles for article (PubMed ID: 18182248)
1. Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis.
Griesbacher T; Pommer V; Schuligoi R; Tiran B; Peskar BA
Int Immunopharmacol; 2008 Feb; 8(2):325-9. PubMed ID: 18182248
[TBL] [Abstract][Full Text] [Related]
2. Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein.
Genovese T; Mazzon E; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Cuzzocrea S
Immunology; 2006 Aug; 118(4):559-70. PubMed ID: 16764691
[TBL] [Abstract][Full Text] [Related]
3. PPAR-gamma knockout in pancreatic epithelial cells abolishes the inhibitory effect of rosiglitazone on caerulein-induced acute pancreatitis.
Ivashchenko CY; Duan SZ; Usher MG; Mortensen RM
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G319-26. PubMed ID: 17463185
[TBL] [Abstract][Full Text] [Related]
4. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury.
Chen C; Xu S; Wang WX; Ding YM; Yu KH; Wang B; Chen XY
Arch Med Res; 2009 Feb; 40(2):79-88. PubMed ID: 19237016
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitous environmental pollutant perfluorooctanoicacid inhibits feeding behavior via peroxisome proliferator-activated receptor-alpha.
Asakawa A; Toyoshima M; Harada KH; Fujimiya M; Inoue K; Koizumi A
Int J Mol Med; 2008 Apr; 21(4):439-45. PubMed ID: 18360689
[TBL] [Abstract][Full Text] [Related]
6. [Effect of peroxisome proliferators-activated receptor-gamma (PPAR gamma) on expression of NF-kB in experimental pancreatitis].
Pei HH; Qiao WH; Bai L; Miao F; Chang JT
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May; 20(5):297-8. PubMed ID: 18471365
[No Abstract] [Full Text] [Related]
7. Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis.
Celiński K; Madro A; Prozorow-Król B; Korolczuk A; Cichoz-Lach H; Słomka M; Korobowicz E
Med Sci Monit; 2009 Jan; 15(1):BR21-9. PubMed ID: 19114961
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen.
Bernardo A; Ajmone-Cat MA; Gasparini L; Ongini E; Minghetti L
J Neurochem; 2005 Feb; 92(4):895-903. PubMed ID: 15686492
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids.
Cuzzocrea S; Bruscoli S; Mazzon E; Crisafulli C; Donato V; Di Paola R; Velardi E; Esposito E; Nocentini G; Riccardi C
Mol Pharmacol; 2008 Feb; 73(2):323-37. PubMed ID: 17984196
[TBL] [Abstract][Full Text] [Related]
11. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
Biscetti F; Gaetani E; Flex A; Aprahamian T; Hopkins T; Straface G; Pecorini G; Stigliano E; Smith RC; Angelini F; Castellot JJ; Pola R
Diabetes; 2008 May; 57(5):1394-404. PubMed ID: 18268046
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction.
Efrati S; Berman S; Chachashvili A; Cohen N; Siman-Tov Y; Averbukh Z; Weissgarten J
Nephrology (Carlton); 2009 Apr; 14(2):189-97. PubMed ID: 19143945
[TBL] [Abstract][Full Text] [Related]
13. Central administration of perfluorooctanoic acid inhibits cutaneous inflammation.
Taylor BK; Kriedt C; Nagalingam S; Dadia N; Badr M
Inflamm Res; 2005 Jun; 54(6):235-42. PubMed ID: 15973506
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
[TBL] [Abstract][Full Text] [Related]
15. PPAR-alpha contributes to the anti-inflammatory activity of 17beta-estradiol.
Crisafulli C; Bruscoli S; Esposito E; Mazzon E; Di Paola R; Genovese T; Bramanti P; Migliorati G; Cuzzocrea S
J Pharmacol Exp Ther; 2009 Dec; 331(3):796-807. PubMed ID: 19755663
[TBL] [Abstract][Full Text] [Related]
16. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.
Lo Verme J; Fu J; Astarita G; La Rana G; Russo R; Calignano A; Piomelli D
Mol Pharmacol; 2005 Jan; 67(1):15-9. PubMed ID: 15465922
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein.
Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Britti D; Patel NS; Di Paola R; Genovese T; Di Rosa M; Caputi AP; Thiemermann C
Intensive Care Med; 2004 May; 30(5):951-6. PubMed ID: 14985957
[TBL] [Abstract][Full Text] [Related]
18. Involvement of glucocorticoid receptor and peroxisome proliferator activated receptor-gamma in pioglitazone mediated chronic gastric ulcer healing in rats.
Lahiri S; Sen T; Palit G
Eur J Pharmacol; 2009 May; 609(1-3):118-25. PubMed ID: 19281808
[TBL] [Abstract][Full Text] [Related]
19. Expression and activation of peroxisome proliferator-activated receptors in growth plate chondrocytes.
Shao YY; Wang L; Hicks DG; Tarr S; Ballock RT
J Orthop Res; 2005 Sep; 23(5):1139-45. PubMed ID: 15878253
[TBL] [Abstract][Full Text] [Related]
20. Glucans from the Caripia montagnei mushroom present anti-inflammatory activity.
Queiroz LS; Nascimento MS; Cruz AK; Castro AJ; Moura Mde F; Baseia IG; Araújo RM; Benevides NM; Lima LF; Leite EL
Int Immunopharmacol; 2010 Jan; 10(1):34-42. PubMed ID: 19804847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
